The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9289467 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 22, 2016

Filed:

Aug. 10, 2012
Applicants:

Feng Lin, Willoughby, OH (US);

James E. Dennis, Cleveland Heights, OH (US);

Zhidan Tu, Cleveland, OH (US);

Inventors:

Feng Lin, Willoughby, OH (US);

James E. Dennis, Cleveland Heights, OH (US);

Zhidan Tu, Cleveland, OH (US);

Assignee:

Case Western Reserve University, Cleveland, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 38/17 (2006.01); A61K 31/7088 (2006.01); A61K 31/713 (2006.01); C07K 16/18 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1725 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 38/177 (2013.01); A61K 39/3955 (2013.01); C07K 16/18 (2013.01);
Abstract

A method of treating a degenerative bone condition of a subject includes administering to hematopoietic progenitor cells or osteoclast progenitor cells of the subject at least one agent that substantially reduces the interaction of at least one of C3a or C5a with the C3a receptor (C3aR) and/or C5a receptor (C5aR), a STAT3/IL-6 signaling pathway antagonist, and a combination thereof, the agent being administered to the hematopoietic progenitor cells or osteoclast progenitor cells at an amount effective to inhibit osteoclast differentiation of hematopoietic progenitor cells or osteoclast progenitor cells.


Find Patent Forward Citations

Loading…